Antibiotics

Rifamycin sodium salt.

Mycobacterial DNA-dependent RNA polymerase inhibitor.

Mycobacterial DNA-dependent RNA polymerase inhibitor.

Mycobacterial DNA-dependent RNA polymerase inhibitor.

Mycobacterial DNA-dependent RNA polymerase inhibitor.

Rifaximin, an orally administered, semi-synthetic, nonsystemic antibiotic derived from rifamycin SV with antibacterial activity.An antibiotic that inhibits RNA synthesis and activates PXR.

Rifaximin, an orally administered, semi-synthetic, nonsystemic antibiotic derived from rifamycin SV with antibacterial activity.An antibiotic that inhibits RNA synthesis and activates PXR.

Rifaximin, an orally administered, semi-synthetic, nonsystemic antibiotic derived from rifamycin SV with antibacterial activity.An antibiotic that inhibits RNA synthesis and activates PXR.

Rifaximin, an orally administered, semi-synthetic, nonsystemic antibiotic derived from rifamycin SV with antibacterial activity.An antibiotic that inhibits RNA synthesis and activates PXR.

Utilized in platelet aggregation experiments.

Ristocetin A is an antibiotic that belongs to the class III glycopeptides. The compound has activity against gram-positive and gram-negative bacteria, and can be used in chromatography. Ristocetin A is structurally related to the glycopeptide

Ristocetin A is an antibiotic that belongs to the class III glycopeptides. The compound has activity against gram-positive and gram-negative bacteria, and can be used in chromatography. Ristocetin A is structurally related to the glycopeptide